Dynamics of mutations during development of resistance by Pseudomonas aeruginosa against five antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 7, 2016, Pages 4229-4236

  Feng, Yanfang ^a   Jonker, Martijs J ^a   Moustakas, Ioannis ^a   Brul, Stanley ^a   Ter Kuile, Benno H ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Food and Consumer Product Safety Authority   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; MEROPENEM; PIPERACILLIN; TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; THIENAMYCIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; CAPD GENE; CELL FUNCTION; CONTROLLED STUDY; CROSS RESISTANCE; ENERGY METABOLISM; ENERGY RESOURCE; FUSA GENE; GENE DUPLICATION; GYRA GENE; GYRB GENE; HP02880 GENE; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; PARC GENE; POINT MUTATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RPLB GENE; SINGLE NUCLEOTIDE POLYMORPHISM; DRUG EFFECTS; ENZYMOLOGY; GENETICS; MICROBIAL SENSITIVITY TEST; MUTATION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CEFTAZIDIME; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; THIENAMYCINS; TOBRAMYCIN;

EID: 84977126109     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00434-16     Document Type: Article

References (49)

1. Toprak E, Veres A, Michel JB, Chait R, Hartl DL, Kishony R. 2012. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet 44:101-105. http://dx.doi.org/10.1038/ng.1034.
2. Andersson DI, Hughes D. 2010. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8:260-271. http://dx.doi.org/10.1038/nrmicro2319.
3. Gifford DR, MacLean RC. 2013. Evolutionary reversals of antibiotic resistance in experimental populations of Pseudomonas aeruginosa. Evolution 67:2973-2981. http://dx.doi.org/10.1111/evo.12158.
4. Feng Y, Händel N, De Groot MHP, Brul S, Schultsz C, Ter Kuile BH. 2014. Experimental simulation of the effects of an initial antibiotic treatment on a subsequent treatment after initial therapy failure. Antibiotics 3:49-63. http://dx.doi.org/10.3390/antibiotics3010049.
5. Kawecki TJ, Lenski RE, Ebert D, Hollis B, Olivieri I, Whitlock MC. 2012. Experimental evolution. Trends Ecol Evol 27:547-560. http://dx.doi.org/10.1016/j.tree.2012.06.001.
6. Spagnolo F, Rinaldi C, Sajorda DR, Dykhuizen DE. 2015. Evolution of resistance to continuously increasing streptomycin concentrations in populations of Escherichia coli. Antimicrob Agents Chemother 60:1336-1342. http://dx.doi.org/10.1128/AAC.01359-15.
7. Tümmler B, Wiehlmann L, Klockgether J, Cramer N. 2014. Advances in understanding Pseudomonas. F1000Prime Rep 6:9. http://dx.doi.org/10.12703/P6-9.
8. Evans CGT, Herbert D, Tempest DW. 1970. The continuous culture of microorganisms, p 209-344. In Norris JR, Ribbons DW (ed), Methods in microbiology, vol 2. Academic Press, Ltd., London, United Kingdom.
9. van der Horst MA, Schuurmans JM, Smid MC, Koenders BB, Ter Kuile BH. 2011. De novo acquisition of resistance to three antibiotics by Escherichia coli. Microb Drug Resist 17:141-147. http://dx.doi.org/10.1089/mdr.2010.0101.
10. Schuurmans JM, Nuri Hayali AS, Koenders BB, ter Kuile BH. 2009. Variations in MIC value caused by differences in experimental protocol. J Microbiol Methods 79:44-47. http://dx.doi.org/10.1016/j.mimet.2009.07.017.
11. Simpson JT, Wong K, Jackman SD, Schein JE, Jones SJ, Birol I. 2009. ABySS: a parallel assembler for short read sequence data. Genome Res 19:1117-1123. http://dx.doi.org/10.1101/gr.089532.108.
12. Chaisson MJ, Tesler G. 2012. Mapping single molecule sequencing reads using basic local alignment with successive refinement (BLASR): application and theory. BMC Bioinformatics 13:238. http://dx.doi.org/10.1186/1471-2105-13-238.
13. Boetzer M, Pirovano W. 2014. SSPACE-LongRead: scaffolding bacterial draft genomes using long read sequence information. BMC Bioinformatics 15:211. http://dx.doi.org/10.1186/1471-2105-15-211.
14. Boetzer M, Pirovano W. 2012. Toward almost closed genomes with GapFiller. Genome Biol 13:R56. http://dx.doi.org/10.1186/gb-2012-13-6-r56.
15. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079. http://dx.doi.org/10.1093/bioinformatics/btp352.
16. Caboche S, Audebert C, Lemoine Y, Hot D. 2014. Comparison of mapping algorithms used in high-throughput sequencing: application to Ion Torrent data. BMC Genomics 15:264. http://dx.doi.org/10.1186/1471-2164-15-264.
17. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754-1760. http://dx.doi.org/10.1093/bioinformatics/btp324.
18. Li H, Durbin R. 2010. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26:589-595. http://dx.doi.org/10.1093/bioinformatics/btp698.
19. Ning Z, Cox AJ, Mullikin JC. 2001. SSAHA: a fast search method for large DNA databases. Genome Res 11:1725-1729. http://dx.doi.org/10.1101/gr.194201.
20. Klambauer G, Schwarzbauer K, Mayr A, Clevert DA, Mitterecker A, Bodenhofer U, Hochreiter S. 2012. cn.MOPS: mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate. Nucleic Acids Res 40:e69. http://dx.doi.org/10.1093/nar/gks003.
21. Dai X, Xiang S, Li J, Gao Q, Yang K. 2012. Development of a colorimetric assay for rapid quantitative measurement of clavulanic acid in microbial samples. Sci China Life Sci 55:158-163. http://dx.doi.org/10.1007/s11427-012-4287-x.
22. Händel N, Schuurmans JM, Feng Y, Brul S, Ter Kuile BH. 2014. Interaction between mutations and regulation of gene expression during development of de novo antibiotic resistance. Antimicrob Agents Chemother 58:4371-4379. http://dx.doi.org/10.1128/AAC.02892-14.
23. Dreier J, Ruggerone P. 2015. Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa. Front Microbiol 6:660. http://dx.doi.org/10.3389/fmicb.2015.00660.
24. Händel N, Schuurmans JM, Brul S, Ter Kuile BH. 2013. Compensation of the metabolic costs of antibiotic resistance by physiological adaptation in Escherichia coli. Antimicrob Agents Chemother 57:3752-3762. http://dx.doi.org/10.1128/AAC.02096-12.
25. Cabot G, Zamorano L, Moyà B, Juan C, Navas A, Blázquez J, Oliver A. 4 January 2016. Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation supply rates. Antimicrob Agents Chemother. http://dx.doi.org/10.1128/AAC.02676-15.
26. Poole K. 2011. Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2:65. http://dx.doi.org/10.3389/fmicb.2011.00065.
27. Morita Y, Tomida J, Kawamura Y. 2014. Responses of Pseudomonas aeruginosa to antimicrobials. Front Microbiol 4:422. http://dx.doi.org/10.3389/fmicb.2013.00422.
28. Cluzet VC, Lautenbach E, Nachamkin I, Cary MS, Fishman NO, Shih NN, Morales KH, Linkin DR. 2015. Risk factors for gyrA and parC mutations in Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 36:387-393. http://dx.doi.org/10.1017/ice.2014.87.
29. Wong A, Rodrigue N, Kassen R. 2012. Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa. PLoS Genet 8:e1002928. http://dx.doi.org/10.1371/journal.pgen.1002928.
30. Feng Y, Hodiamont CJ, van Hest RM, Brul S, Schultsz C, Ter Kuile BH. 2016. Development of antibiotic resistance during simulated treatment of Pseudomonas aeruginosa in chemostats. PLoS One 11:e0149310. http://dx.doi.org/10.1371/journal.pone.0149310.
31. Wang D, Dorosky RJ, Han CS, Lo CC, Dichosa AE, Chain PS, Yu JM, Pierson LS, III, Pierson EA. 2015. Adaptation genomics of a small-colony variant in a Pseudomonas chlororaphis 30-84 biofilm. Appl Environ Microbiol 81:890-899. http://dx.doi.org/10.1128/AEM.02617-14.
32. Chandler JR, Truong TT, Silva PM, Seyedsayamdost MR, Carr G, Radey M, Jacobs MA, Sims EH, Clardy J, Greenberg EP. 2012. Bactobolin resistance is conferred by mutations in the L2 ribosomal protein. mBio 3:e00499-12. http://dx.doi.org/10.1128/mBio.00499-12.
33. Li W, Ulm H, Rausch M, Li X, O'Riordan K, Lee JC, Schneider T, Muller CE. 2014. Analysis of the Staphylococcus aureus capsule biosynthesis pathway in vitro: characterization of the UDP-GlcNAc C6 dehydratases CapD and CapE and identification of enzyme inhibitors. Int J Med Microbiol 304:958-969. http://dx.doi.org/10.1016/j.ijmm.2014.06.002.
34. Cabot G, Bruchmann S, Mulet X, Zamorano L, Moya B, Juan C, Haussler S, Oliver A. 2014. Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC. Antimicrob Agents Chemother 58:3091-3099. http://dx.doi.org/10.1128/AAC.02462-13.
35. Pai H, Kim J, Kim J, Lee JH, Choe KW, Gotoh N. 2001. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 45:480-484. http://dx.doi.org/10.1128/AAC.45.2.480-484.2001.
36. Bratu S, Landman D, Gupta J, Quale J. 2007. Role of AmpD, OprF and penicillin-binding proteins in beta-lactam resistance in clinical isolates of Pseudomonas aeruginosa. J Med Microbiol 56:809-814. http://dx.doi.org/10.1099/jmm.0.47019-0.
37. Moya B, Dotsch A, Juan C, Blazquez J, Zamorano L, Haussler S, Oliver A. 2009. Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein. PLoS Pathog 5:e1000353. http://dx.doi.org/10.1371/journal.ppat.1000353.
38. Vestergaard M, Paulander W, Marvig RL, Clasen J, Jochumsen N, Molin S, Jelsbak L, Ingmer H, Folkesson A. 2016. Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa. Int J Antimicrob Agents 47:48-55. http://dx.doi.org/10.1016/j.ijantimicag.2015.09.014.
39. Zhang W, Lee M, Hesek D, Lastochkin E, Boggess B, Mobashery S. 2013. Reactions of the three AmpD enzymes of Pseudomonas aeruginosa. J Am Chem Soc 135:4950-4953. http://dx.doi.org/10.1021/ja400970n.
40. Lang GI, Rice DP, Hickman MJ, Sodergren E, Weinstock GM, Botstein D, Desai MM. 2013. Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations. Nature 500:571-574. http://dx.doi.org/10.1038/nature12344.
41. Lieberman TD, Flett KB, Yelin I, Martin TR, McAdam AJ, Priebe GP, Kishony R. 2014. Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. Nat Genet 46:82-87. http://dx.doi.org/10.1038/ng.2848.
42. Nguyen D, Singh PK. 2006. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc Natl Acad Sci U S A 103:8305-8306. http://dx.doi.org/10.1073/pnas.0602526103.
43. Lee HH, Molla MN, Cantor CR, Collins JJ. 2010. Bacterial charity work leads to population-wide resistance. Nature 467:82-85. http://dx.doi.org/10.1038/nature09354.
44. Fernández L, Breidenstein EB, Hancock RE. 2011. Creeping baselines and adaptive resistance to antibiotics. Drug Resist Updat 14:1-21. http://dx.doi.org/10.1016/j.drup.2011.01.001.
45. Andersson DI. 2006. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 9:461-465. http://dx.doi.org/10.1016/j.mib.2006.07.002.
46. Russell JB, Cook GM. 1995. Energetics of bacterial growth: balance of anabolic and catabolic reactions. Microbiol Rev 59:48-62.
47. Roux D, Danilchanka O, Guillard T, Cattoir V, Aschard H, Fu Y, Angoulvant F, Messika J, Ricard JD, Mekalanos JJ, Lory S, Pier GB, Skurnik D. 2015. Fitness cost of antibiotic susceptibility during bacterial infection. Sci Transl Med 7:297ra114. http://dx.doi.org/10.1126/scitranslmed.aab1621.
48. Kohanski MA, Dwyer DJ, Collins JJ. 2010. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 8:423-435. http://dx.doi.org/10.1038/nrmicro2333.
49. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. http://dx.doi.org/10.1016/j.cell.2007.06.049.